Literature DB >> 33407228

What stakeholders think: perceptions of perinatal depression and screening in China's primary care system.

Shahirose Sadrudin Premji1, Keith S Dobson2, Anupa Prashad3, Shelby Yamamoto4, Fangbiao Tao5,6, Beibei Zhu5, Xiaoyan Wu5, Mengjuan Lu5, Shanshan Shao5.   

Abstract

BACKGROUND: Mental health in China is a significant issue, and perinatal depression has been recognized as a concern, as it may affect pregnancy outcomes. There are growing calls to address China's mental health system capacity issues, especially among vulnerable groups such as pregnant women due to gaps in healthcare services and inadequate access to resources and support. In response to these demands, a perinatal depression screening and management (PDSM) program was proposed. This exploratory case study identified strategies for successful implementation of the proposed PDSM intervention, informed by the Consolidated Framework for Implementation Research (CFIR) framework, in Ma'anshan city, Anhui province.
METHODS: This qualitative study included four focus group discussions and two in-depth individual interviews with participants using a semi-structured interview guide. Topics examined included acceptance, utility, and readiness for a PDSM program. Participants included perinatal women and their families, policymakers, and healthcare providers. Interviews were transcribed verbatim, coded, and analyzed for emergent themes.
RESULTS: The analysis revealed several promising factors for the implementation of the PDSM program including: utilization of an internet-based platform, generation of perceived value among health leadership and decision-makers, and the simplification of the screening and intervention components. Acceptance of the pre-implementation plan was dependent on issues such as the timing and frequency of screening, ensuring high standards of quality of care, and consideration of cultural values in the intervention design. Potential challenges included perceived barriers to the implementation plan among stakeholders, a lack of trained human health resources, and poor integration between maternal and mental health services. In addition, participants expressed concern that perinatal women might not value the PDSM program due to stigma and limited understanding of maternal mental health issues.
CONCLUSION: Our analysis suggests several factors to support the successful implementation of a perinatal depression screening program, guidelines for successful uptake, and the potential use of internet-based cognitive behavioral therapy. PDSM is a complex process; however, it can be successfully navigated with evidence-informed approaches to the issues presented to ensure that the PDSM is feasible, effective, successful, and sustainable, and that it also improves maternal health and wellbeing, and that of their families.

Entities:  

Keywords:  CFIR; Implementation science; Perinatal depression; Qualitative

Mesh:

Year:  2021        PMID: 33407228      PMCID: PMC7789622          DOI: 10.1186/s12884-020-03473-y

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  39 in total

Review 1.  Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review.

Authors:  Jane Fisher; Meena Cabral de Mello; Vikram Patel; Atif Rahman; Thach Tran; Sara Holton; Wendy Holmes
Journal:  Bull World Health Organ       Date:  2011-11-24       Impact factor: 9.408

2.  Postpartum depression prevalence and impact on infant health, weight, and sleep in low-income and ethnic minority women and infants.

Authors:  Jenna L Gress-Smith; Linda J Luecken; Kathryn Lemery-Chalfant; Rose Howe
Journal:  Matern Child Health J       Date:  2012-05

3.  Maternal depressive symptoms and children's receipt of health care in the first 3 years of life.

Authors:  Cynthia S Minkovitz; Donna Strobino; Dan Scharfstein; William Hou; Tess Miller; Kamila B Mistry; Karen Swartz
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

4.  [The occurrence and determinants of anxiety and depression symptoms in women of six counties/ districts in China during pregnancy].

Authors:  H Q Hu; J Zhang; W Zhao; T Tian; A Q Huang; L L Wang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2017-01-06

5.  A rural perspective on perinatal depression: prevalence, correlates, and implications for help-seeking among low-income women.

Authors:  Sarah Kye Price; Enola K Proctor
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

6.  A prevalence study of antenatal depression among Chinese women.

Authors:  Dominic T S Lee; Sandra S M Chan; Daljit S Sahota; Alexander S K Yip; Michelle Tsui; Tony K H Chung
Journal:  J Affect Disord       Date:  2004-10-01       Impact factor: 4.839

7.  Prevalence, course, and risk factors for antenatal anxiety and depression.

Authors:  Antoinette M Lee; Siu Keung Lam; Stephanie Marie Sze Mun Lau; Catherine Shiu Yin Chong; Hang Wai Chui; Daniel Yee Tak Fong
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

Review 8.  Enhancing Participation in Depression Care in Outpatient Perinatal Care Settings: A Systematic Review.

Authors:  Nancy Byatt; Leonard L Levin; Douglas Ziedonis; Tiffany A Moore Simas; Jeroan Allison
Journal:  Obstet Gynecol       Date:  2015-11       Impact factor: 7.661

9.  Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation.

Authors:  Rosalind E Keith; Jesse C Crosson; Ann S O'Malley; DeAnn Cromp; Erin Fries Taylor
Journal:  Implement Sci       Date:  2017-02-10       Impact factor: 7.327

10.  Beyond the Trial: Systematic Review of Real-World Uptake and Engagement With Digital Self-Help Interventions for Depression, Low Mood, or Anxiety.

Authors:  Theresa Fleming; Lynda Bavin; Mathijs Lucassen; Karolina Stasiak; Sarah Hopkins; Sally Merry
Journal:  J Med Internet Res       Date:  2018-06-06       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.